Works matching DE "CETUXIMAB"

Results: 1696

First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis.

Published in:

PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0324057

By:

Li, Huijuan;
Liang, Xueyan;
Qin, Shiran;
Chen, Xiaoyu;
Huang, Liju;
Li, Yan

Publication type:

Article

Carvacrol enhances the sensitivity of cetuximab in lung cancer cells through inducing apoptosis and cell cycle arrest.

Published in:

Bangladesh Journal of Pharmacology, 2025, v. 20, n. 1, p. 22, doi. 10.3329/bjp.v20i1.80949

By:

Erdogan, Ayse;
Koras, Rahime Aybike

Publication type:

Article

A pediatric case report of fixed drug eruption related to carmoisine colorant present in paracetamol syrup.

Published in:

Indian Journal of Pharmacology, 2019, v. 51, n. 4, p. 279, doi. 10.4103/ijp.IJP_29_19

By:

Panachiyil, George;
Babu, Tirin;
Sebastian, Juny;
Doddaiah, Narayanappa

Publication type:

Article

Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy.

Published in:

Indian Journal of Pharmacology, 2011, v. 43, n. 4, p. 478, doi. 10.4103/0253-7613.83135

By:

Gupta, Deepak;
Shukla, Pragya;
Bisht, Shyam Singh;
Bhatt, M. L. B.;
Pant, M. C.;
Srivastava, Kirti

Publication type:

Article

Analysis of main pathogenic bacteria and drug sensitivity in patients with chronic suppurative otitis media and middle ear cholesteatoma in China.

Published in:

Biotechnology Letters, 2020, v. 42, n. 8, p. 1559, doi. 10.1007/s10529-020-02880-7

By:

Xu, Feng;
Kong, Weili;
Peng, Jiaojiao;
Gu, Hailing;
Zheng, Hong

Publication type:

Article

Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 871, doi. 10.1007/s00280-011-1559-2

By:

Liu, Xin;
Guo, Wei-Jian;
Zhang, Xiao-Wei;
Cai, Xu;
Tian, Shu;
Li, Jin

Publication type:

Article

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 1045, doi. 10.1007/s00280-011-1586-z

By:

Park, Jin;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Jeong, Seung-Yong;
Park, Kyu;
Kim, Tae-You;
Bang, Yung-Jue;
Park, Jae-Gahb

Publication type:

Article

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 891, doi. 10.1007/s00280-010-1383-0

By:

Arnoletti, J.;
Frolov, A.;
Eloubeidi, M.;
Keene, K.;
Posey, J.;
Wood, T.;
Greeno, Edward;
Jhala, N.;
Varadarajulu, S.;
Russo, S.;
Christein, J.;
Oster, R.;
Buchsbaum, D.;
Vickers, S.

Publication type:

Article

Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 339, doi. 10.1007/s00280-010-1327-8

By:

Lévi, Francis;
Karaboué, Abdoulaye;
Gorden, Lee;
Innominato, Pasquale;
Saffroy, Raphael;
Giacchetti, Sylvie;
Hauteville, Dominique;
Guettier, Catherine;
Adam, René;
Bouchahda, Mohamed

Publication type:

Article

Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 849, doi. 10.1007/s00280-009-1090-x

By:

Lidan Liu;
Yunfei Cao;
Aihua Tan;
Cun Liao;
Feng Gao

Publication type:

Article

Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 107, doi. 10.1007/s00280-009-1009-6

By:

Saif, Muhammad Wasif;
Syrigos, K. I.;
Hotchkiss, S.;
Shanley, J.;
Grasso, J.;
Ferencz, T. M.;
Shah, M. M.

Publication type:

Article

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 3, p. 557, doi. 10.1007/s00280-008-0904-6

By:

Shirao, Kuniaki;
Yoshino, Takayuki;
Boku, Narikazu;
Kato, Ken;
Hamaguchi, Tetsuya;
Yasui, Hisateru;
Yamamoto, Nobuyuki;
Tanigawara, Yusuke;
Nolting, Arno;
Yoshino, Shinichiro

Publication type:

Article

Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1017, doi. 10.1007/s00280-008-0831-6

By:

Saif, Muhammad Wasif;
Peccerillo, J.;
Potter, Von

Publication type:

Article

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x

By:

Chia-Chi Lin;
Calvo, Emiliano;
Papadopoulos, Kyriakos P.;
Patnaik, Amita;
Sarantopoulos, John;
Mita, Alain C.;
Preston, Glenn G.;
Mita, Monica M.;
Rodon, Jordi;
Mays, Theresa;
I.-Tien Yeh;
O'Rourke, Pat;
Takimoto, Chris H.;
Dancey, Janet E.;
Chen, Helen;
Tolcher, Anthony W.

Publication type:

Article

Third-line therapy for metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 1, doi. 10.1007/s00280-007-0573-x

By:

Gundgaard, M. G.;
Soerensen, J. B.;
Ehrnrooth, E.

Publication type:

Article

In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.

Published in:

Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 709, doi. 10.1007/s00280-005-0123-3

By:

Balin-Gauthier, Diane;
Delord, Jean-Pierre;
Rochaix, Philippe;
Mallard, Valérie;
Thomas, Fabienne;
Hennebelle, Isabelle;
Bugat, Roland;
Canal, Pierre;
Allal, Cuider

Publication type:

Article

Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 455, doi. 10.1007/s00280-005-1022-3

By:

Luo, F. R.;
Yang, Z.;
Dong, H.;
Camuso, A.;
McGlinchey, K.;
Fager, K.;
Flefleh, C.;
Kan, D.;
Inigo, I.;
Castaneda, S.;
Rose, W. C.;
Kramer, R. A.;
Wild, R.;
Lee, F. Y.

Publication type:

Article

Genetic Polymorphisms of FcγRIIa and FcγRIIIa Are Not Predictive of Clinical Outcomes after Cetuximab plus Irinotecan Chemotherapy in Patients with Metastatic Colorectal Cancer.

Published in:

Oncology, 2012, v. 82, n. 2, p. 83, doi. 10.1159/000335959

By:

Park, Seong Joon;
Hong, Yong Sang;
Lee, Jae-Lyun;
Ryu, Min-Hee;
Chang, Heung Moon;
Kim, Kyu-pyo;
Ahn, Yong Chel;
Na, Young-Soon;
Jin, Dong-Hoon;
Yu, Chang Sik;
Kim, Jin Cheon;
Kang, Yoon-Koo;
Kim, Tae Won

Publication type:

Article

Prolonged Survival of Patients with Metastatic Colorectal Cancer following First-Line Oxaliplatin-Based Chemotherapy with Molecular Targeting Agents and Curative Surgery.

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 167, doi. 10.1159/000333404

By:

Shitara, Kohei;
Matsuo, Keitaro;
Kondo, Chihiro;
Takahari, Daisuke;
Ura, Takashi;
Inaba, Yoshitaka;
Yamaura, Hidekazu;
Sato, Yozo;
Kato, Mina;
Kanemitsu, Yukihide;
Komori, Koji;
Ishiguro, Seiji;
Sano, Tsuyoshi;
Shimizu, Yasuhiro;
Muro, Kei

Publication type:

Article

KRAS Mutation in Metastatic Pancreatic Ductal Adenocarcinoma: Results of a Multicenter Phase II Study Evaluating Efficacy of Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Therapy.

Published in:

Oncology, 2011, v. 81, n. 1, p. 3, doi. 10.1159/000330194

By:

Kullmann, F.;
Hartmann, A.;
Stöhr, R.;
Messmann, H.;
Dollinger, M.M.;
Trojan, J.;
Fuchs, M.;
Hollerbach, S.;
Harder, J.;
Troppmann, M.;
Kutscheidt, A.;
Endlicher, E.

Publication type:

Article

Reply to Dr. Kabbinavar and Dr. Kozloff.

Published in:

Oncology, 2011, v. 80, n. 1/2, p. 140, doi. 10.1159/000327226

By:

Stathopoulos, G.P.

Publication type:

Article

Cetuximab plus FOLFOX-4 in Untreated Patients with Advanced Colorectal Cancer: A Gruppo Oncologico dell'Italia Meridionale Multicenter Phase II Study.

Published in:

Oncology, 2011, v. 79, n. 5/6, p. 415, doi. 10.1159/000323279

By:

Colucci, Giuseppe;
Giuliani, Francesco;
Garufi, Carlo;
Mattioli, Rodolfo;
Manzione, Luigi;
Lopez, Massimo;
Parrella, Paola;
Tommasi, Stefania;
Copetti, Massimiliano;
Daniele, Bruno;
Pisconti, Salvatore;
Tuveri, Guido;
Silvestris, Nicola;
Maiello, Evaristo;
Russo, Antonio

Publication type:

Article

The Long and Winding Road to Useful Predictive Factors for Anti-EGFR Therapy in Metastatic Colorectal Carcinoma: The KRAS/BRAF Pathway.

Published in:

Oncology, 2009, v. 77, p. 57, doi. 10.1159/000258497

By:

Russo, Antonio;
Rizzo, Sergio;
Bronte, Giuseppe;
Silvestris, Nicola;
Colucci, Giuseppe;
Gebbia, Nicola;
Bazan, Viviana;
Fulfaro, Fabio

Publication type:

Article

The Dark Side of the Moon: The PI3K/PTEN/AKT Pathway in Colorectal Carcinoma.

Published in:

Oncology, 2009, v. 77, p. 69, doi. 10.1159/000258498

By:

Silvestris, Nicola;
Tommasi, Stefania;
Petriella, Daniela;
Santini, Daniele;
Fistola, Ettore;
Russo, Antonio;
Numico, Gianmauro;
Tonini, Giuseppe;
Maiello, Evaristo;
Colucci, Giuseppe

Publication type:

Article

The Role of KRAS Mutations in Predicting the Efficacy of Cetuximab-Plus-Irinotecan Therapy in Irinotecan-Refractory Korean Metastatic Colorectal Cancer Patients.

Published in:

Oncology, 2009, v. 77, n. 3/4, p. 224, doi. 10.1159/000236046

By:

Byeong Seok Sohn;
Tae Won Kim;
Jae-Lyun Lee;
Min-Hee Ryu;
Heung Moon Chang;
Yoon-Koo Kang;
Hyo Suk Park;
Young-Soon Na;
Se Jin Jang;
Jin Cheon Kim;
Jung Shin Lee

Publication type:

Article

Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis.

Published in:

Oncology, 2009, v. 77, n. 2, p. 124, doi. 10.1159/000229752

By:

Xiao Su;
Lacouture, Mario E.;
Yuxia Jia;
Shenhong Wu

Publication type:

Article

Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147.

Published in:

Oncology, 2009, v. 77, n. 2, p. 120, doi. 10.1159/000229751

By:

Jatoi, Aminah;
Green, Erin M.;
Rowland Jr., Kendrith M.;
Sargent, Daniel J.;
Alberts, Steven R.

Publication type:

Article

Response to Reintroduction of Cetuximab in 5 Patients with Advanced, Chemotherapy-Resistant, Colorectal Cancer without Progressive Disease following First-Line Therapy with a Cetuximab-Containing Regimen.

Published in:

Oncology, 2008, v. 74, n. 3/4, p. 123, doi. 10.1159/000151358

By:

Kaechele, Volker;
von Wichert, Goetz;
Adler, Guido;
Seufferlein, Thomas

Publication type:

Article

Assessment of Baseline Clinical Predictive Factors of Response to Cetuximab-Irinotecan in Patients with Irinotecan-Refractory Metastatic Colorectal Cancer.

Published in:

Oncology, 2007, v. 73, n. 3/4, p. 185, doi. 10.1159/000127385

By:

Hebbar, Mohamed;
Di Fioré, Frédéric;
Conroy, Thierry;
Giraud, Claire;
Gasnault, Laurent;
Fournier, Charles;
Péreira, Renata;
Bouché, Olivier;
Fournier, Peggy;
Deligny, Nathalie;
Joly, Jean-Paul;
Maes, Patricia;
Rad, Emilia;
Michel, Pierre;
Adenis, Antoine

Publication type:

Article

Feasibility of Using Cetuximab and Bevacizumab in a Patient with Colorectal Cancer and Terminal Renal Failure.

Published in:

Oncology, 2007, v. 72, n. 3/4, p. 209, doi. 10.1159/000112828

By:

Inauen, R.;
Cathomas, R.;
Boehm, T.;
Koeberle, D.;
Pestalozzi, B. C.;
Gillessen, S.;
Von Moos, R.

Publication type:

Article

Cetuximab plus Gemcitabine-Oxaliplatin (GEMOX) in Patients with Refractory Advanced Intrahepatic Cholangiocarcinomas.

Published in:

Oncology, 2007, v. 72, n. 1/2, p. 105, doi. 10.1159/000111117

By:

Paule, Bernard;
Herelle, Marie-Olga;
Rage, Estelle;
Ducreux, Michel;
Adam, René;
Guettier, Catherine;
Bralet, Marie-Pierre

Publication type:

Article

The Role of New Agents in the Treatment of Colorectal Cancer.

Published in:

Oncology, 2004, v. 66, n. 1, p. 1, doi. 10.1159/000076329

By:

Folprecht, Gunnar;
Köhne, Claus-Henning

Publication type:

Article

Perspectives on Anti-HER Monoclonal Antibodies.

Published in:

Oncology, 2002, v. 63, p. 17, doi. 10.1159/000066203

By:

Ranson, Malcolm;
Sliwkowski, Mark X.

Publication type:

Article

Endoscopic fully covered self-expandable metal stent and vacuum-assisted drainage to treat postoperative colorectal cancer anastomotic stenosis with fistula.

Published in:

Surgical Endoscopy & Other Interventional Techniques, 2023, v. 37, n. 5, p. 3780, doi. 10.1007/s00464-022-09831-5

By:

Deng, Shenghe;
Liu, Ke;
Gu, Junnan;
Cao, Yinghao;
Mao, Fuwei;
Xue, Yifan;
Jiang, Zhenxing;
Qin, Le;
Wu, Ke;
Cai, Kailin

Publication type:

Article

Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study.

Published in:

Surgical Endoscopy & Other Interventional Techniques, 2022, v. 36, n. 5, p. 3374, doi. 10.1007/s00464-021-08655-z

By:

Barkhatov, Leonid;
Aghayan, Davit L.;
Scuderi, Vincenzo;
Cipriani, Federica;
Fretland, Åsmund A.;
Kazaryan, Airazat M.;
Ratti, Francesca;
Armstrong, Thomas;
Belli, Andrea;
Dagher, Ibrahim;
Belli, Giulio;
Aldrighetti, Luca;
Hilal, Mohammad Abu;
Troisi, Roberto I.;
Edwin, Bjørn

Publication type:

Article

The efficacy of the submucosal injection of lidocaine during endoscopic submucosal dissection for colorectal neoplasms: a multicenter randomized controlled study.

Published in:

Surgical Endoscopy & Other Interventional Techniques, 2021, v. 35, n. 9, p. 5225, doi. 10.1007/s00464-020-08017-1

By:

Ijiri, Masami;
Sasaki, Takahiro;
Fujiya, Mikihiro;
Iwama, Takuya;
Murakami, Yuki;
Takahashi, Keitaro;
Tanaka, Kazuyuki;
Ando, Katsuyoshi;
Ueno, Nobuhiro;
Kashima, Shin;
Moriichi, Kentaro;
Tanabe, Hiroki;
Saito, Yusuke;
Okumura, Toshikatsu

Publication type:

Article

Analgesic efficacy of pre-emptive local wound infiltration plus laparoscopic-assisted transversus abdominis plane block versus wound infiltration in patients undergoing laparoscopic colorectal resection: results from a randomized, multicenter, single-blind, non-inferiority trial.

Published in:

2021

By:

Pedrazzani, Corrado;
Park, Soo Yeun;
Conti, Cristian;
Turri, Giulia;
Park, Jun Seok;
Kim, Hye Jin;
Polati, Enrico;
Guglielmi, Alfredo;
Choi, Gyu Seog

Publication type:

journal article

Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00418-4

By:

Al-Sudani, Hussein;
Ni, Ying;
Jones, Philip;
Karakilic, Huseyin;
Cui, Lei;
Johnson, Lisa D. S.;
Rose, Peter G.;
Olawaiye, Alexander;
Edwards, Robert P.;
Uger, Robert A.;
Lin, Gloria H. Y.;
Mahdi, Haider

Publication type:

Article

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00329-w

By:

McFall, Thomas;
Trogdon, Michael;
Guizar, Anita C.;
Langenheim, John F.;
Sisk-Hackworth, Laura;
Stites, Edward C.

Publication type:

Article

A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.

Published in:

Immunopharmacology & Immunotoxicology, 2023, v. 45, n. 1, p. 1, doi. 10.1080/08923973.2022.2112222

By:

Liu, Tong;
Jiang, Shuai;
Teng, Xue;
Zhong, Lu;
Liu, Mengmeng;
Jin, Yao;
Dong, Mei

Publication type:

Article

THE REAL-WORLD COST AND EFFECTIVENESS STUDY OF TREATING mCRC WITH BEVACIZUMAB FOLLOWED BY CETUXIMAB OR PANITUMUMAB IN WT KRAS PATIENTS.

Published in:

Farmacia, 2020, v. 68, n. 3, p. 572, doi. 10.31925/farmacia.2020.3.25

By:

SEHNALOVA, IRENA;
RIHOVA, BARBORA;
NEMECEK, RADIM;
KINTROVA, KATERINA;
DEMLOVA, REGINA

Publication type:

Article

Multiple recurrent cutaneous squamous cell carcinomas in situ secondary to epidermodysplasia verruciformis: A case report and successful treatment with aminolevulinic acid photodynamic therapy.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2024, v. 40, n. 1, p. 1, doi. 10.1111/phpp.12928

By:

Wang, Shiwen;
Zhao, Yige;
Tang, Chenyu;
Wang, Panpan;
Ma, Yangyang;
Zhu, Mengyan;
Wang, Jiaqi;
Wang, Ping

Publication type:

Article

Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real‐life experience from a single tertiary center.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2023, v. 39, n. 5, p. 428, doi. 10.1111/phpp.12872

By:

Doğan, Pelin Ertop;
Akay, Bengü Nisa;
Vural, Seçil;
Arı, Canan;
Yılmaz, Tuğçe Ertürk;
Şanlı, Hatice

Publication type:

Article

Cetuximab-Taxanes-Platinum-Fluorouracil/ Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation.

Published in:

Medicina Moderna, 2023, v. 30, n. 1, p. 23, doi. 10.31689/rmm.2023.30.1.23

By:

MIRESTEAN, Camil Ciprian;
IANCU, Roxana Irina;
STAN, Mihai Cosmin;
IANCU, Dragos Petru Teodor;
BADULESCU, Florinel

Publication type:

Article

A novel fusion between CDC42BPB and ALK in a patient with quadruple wild‐type gastrointestinal stromal tumor.

Published in:

Molecular Genetics & Genomic Medicine, 2022, v. 10, n. 5, p. 1, doi. 10.1002/mgg3.1881

By:

Huang, Wen;
Yuan, Wei;
Ren, Lei;
Xu, Chen;
Luo, Rongkui;
Zhou, Yuhong;
Lu, Weiqi;
Hao, Qing;
Xu, Mian;
Hou, Yingyong

Publication type:

Article

A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy.

Published in:

Experimental Dermatology, 2019, v. 28, n. 5, p. 614, doi. 10.1111/exd.13920

By:

Minabe, Masaki;
Akiyama, Yurie;
Higa, Kazunari;
Tachikawa, Tetsuhiko;
Takahashi, Shinichi;
Nomura, Takeshi;
Kouno, Michiyoshi

Publication type:

Article

Association between EGFR gene polymorphisms, skin rash and response to anti- EGFR therapy in metastatic colorectal cancer patients.

Published in:

Experimental Dermatology, 2014, v. 23, n. 10, p. 751, doi. 10.1111/exd.12510

By:

Jaka, Ane;
Gutiérrez‐Rivera, Araika;
Ormaechea, Nerea;
Blanco, Jesus;
La Casta, Adelaida;
Sarasqueta, Cristina;
Izeta, Ander;
Tuneu, Anna

Publication type:

Article

Psoriasis induced by cetuximab: A paradoxical adverse effect.

Published in:

Australasian Journal of Dermatology, 2011, v. 52, n. 1, p. 56, doi. 10.1111/j.1440-0960.2010.00675.x

By:

Mas-Vidal, Albert;
Coto-Segura, Pablo;
Galache-Osuna, Cristina;
Santos-Juanes, Jorge

Publication type:

Article

Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52897-5

By:

Song, Patrick N.;
Lynch, Shannon E.;
DeMellier, Chloe T.;
Mansur, Ameer;
Gallegos, Carlos A.;
Wright, Brian D.;
Hartman, Yolanda E.;
Minton, Laura E.;
Lapi, Suzanne E.;
Warram, Jason M.;
Sorace, Anna G.

Publication type:

Article

Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52034-2

By:

Feng, Jia;
Chen, Xinyi;
Wei, Jiayan;
Weng, Yiming;
Wang, Jingsong;
Wang, Tong;
Song, Qibin;
Min, Peng

Publication type:

Article